Abstract
The worldwide rise in antibiotic resistance necessitates the development of novel antimicrobial strategies. Although many workers have used photodynamic therapy (PDT) to kill bacteria in vitro, the use of this approach has seldom been reported in vivo in animal models of infection. We have previously described the first use of PDT to treat excisional wound infections by Gram-(-) bacteria in living mice. However, these infected wound models involved a short timespan between infection (30 min) and treatment by PDT. We now report on the use of PDT to treat an established soft-tissue infection in mice. We used Staphylococcus aureus stably transformed with a Photorhabdus luminescenslux operon (luxABCDE) that was genetically modified to be functional in Gram-(+) bacteria. These engineered bacteria emitted bioluminescence, allowing the progress of the infection to be monitored in both space and time with a low light imaging charge-coupled device (CCD) camera. One million cells were injected into one or both thigh muscles of mice that had previously been rendered neutropenic by cyclophosphamide administration. Twenty-four hours later, the bacteria had multiplied more than one hundredfold; poly-l-lysine chlorin e6 conjugate or free chlorin e6 was injected into one area of infected muscle and imaged with the CCD camera. Thirty minutes later, red light from a diode laser was delivered as a surface spot or by interstitial fiber into the infection. There was a light dose dependent loss of bioluminescence (to <5% of that seen in control infections) not seen in untreated infections or those treated with light alone, but in some cases, the infection recurred. Treatment with conjugate alone led to a lesser reduction in bioluminescence. Infections treated with free chlorin e6 responded less well and the infection subsequently increased over the succeeding days, probably due to PDT-mediated tissue damage. PDT-treated infected legs healed better than legs with untreated infections. This data shows that PDT may have applications in drug-resistant soft-tissue infections.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst., 1998, 90, 889–905.
H. Von Tappeiner and A. Jodlbauer, Ueber wirkung der photodynamischen (fluorescierenden) Stoffe auf Protozoan und enzyme, Dtsch. Arch. Klin. Med., 1904, 80, 422–487.
M. Wainwright, Photodynamic antimicrobial chemotherapy (PACT), J. Antimicrob. Chemother., 1998, 42, 13–28.
A. R. Hinman, Global progress in infectious disease control, Vaccine, 1998, 16, 1116–1121.
M. Michel and L. Gutmann, Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities, Lancet, 1997, 349, 1901–1906.
M. Wilson and C. Yianni, Killing of methicillin-resistant Staphylococcus aureus by low-power laser light, J. Med. Microbiol., 1995, 42, 62–66.
M. Wainwright, D. A. Phoenix, S. L. Laycock, D. R. Wareing and P. A. Wright, Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus, FEMS Microbiol. Lett., 1998, 160, 177–181.
N. S. Soukos, L. A. Ximenez-Fyvie, M. R. Hamblin, S. S. Socransky and T. Hasan, Targeted antimicrobial photochemotherapy, Antimicrob. Agents Chemother., 1998, 42, 2595–2601.
M. R. Hamblin, D. A. O’Donnell, N. Murthy, K. Rajagopalan, N. Michaud, M. E. Sherwood and T. Hasan, Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria, J. Antimicrob. Chemother., 2002, 49, 941–951.
M. R. Hamblin, D. A. O’Donnell, N. Murthy, C. H. Contag and T. Hasan, Photodynamic treatment of wound infections in vivo monitored by luminescence imaging, Photochem. Photobiol., 2002, 75, 51–57.
H. L. Rocchetta, C. J. Boylan, J. W. Foley, P. W. Iversen, D. L. LeTourneau, C. L. McMillian, P. R. Contag, D. E. Jenkins and T. R. Parr, Jr., Validation of a noninvasive, real-time imaging technology using bioluminescent escherichia coli in the neutropenic mouse thigh model of infection, Antimicrob. Agents Chemother., 2001, 45, 129–137.
C. H. Contag, P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson and D. A. Benaron, Photonic detection of bacterial pathogens in living hosts, Mol. Microbiol., 1995, 18, 593–603.
M. R. Hamblin, T. Zahra, C. H. Contag, A. T. McManus and T. Hasan, Optical monitoring and treatment of potentially lethal wound infections in vivo, J. Infect. Dis., 2003, 187, 1717–1725.
M. R. Hamblin, D. A. O’Donnell, N. Murthy, C. H. Contag and T. Hasan, Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging, Photochem. Photobiol., 2002, 75, 51–57.
P. Phonimdaeng, M. O’Reilly, P. Nowlan, A. J. Bramley and T. J. Foster, The coagulase of Staphylococcus aureus 8325–4. Sequence analysis and virulence of site-specific coagulase-deficient mutants, Mol. Microbiol., 1990, 4, 393–404.
K. P. Francis, D. Joh, C. Bellinger-Kawahara, M. J. Hawkinson, T. F. Purchio and P. R. Contag, Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct, Infect. Immun., 2000, 68, 3594–3600.
K. P. Francis, J. Yu, C. Bellinger-Kawahara, D. Joh, M. J. Hawkinson, G. Xiao, T. F. Purchio, M. G. Caparon, M. Lipsitch and P. R. Contag, Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon, Infect. Immun., 2001, 69, 3350–3358.
O. Zak and T. O’Reilly, Animal infection models and ethics: the perfect infection model, J. Antimicrob. Chemother., 1993, 31, 193–205.
J. W. van der Meer, M. Barza, S. M. Wolff and C. A. Dinarello, A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection, Proc. Natl. Acad. Sci. U. S. A., 1988, 85, 1620–1623.
N. Komerik, M. Wilson and S. Poole, The effect of photodynamic action on two virulence factors of gram-negative bacteria, Photochem. Photobiol., 2000, 72, 676–680.
F. Berthiaume, S. Reiken, M. Toner, R. Tompkins and M. Yarmush, Antibody-targeted photolysis of bacteria in vivo, Biotechnology, 1994, 12, 703–706.
G. F. Lombard, S. Tealdi and M. M. Lanotte, The treatment of neurosurgical infections by lasers and porphyrins, in Photodynamic Therapy of Tumors and other Diseases, ed. G. Jori and C. A. Perria, Edizione Libreria Progetto, Padova, 1985, pp. 363–366.
C. Perry, Methicillin-resistant Staphylococcus aureus, J. Wound Care, 1996, 5, 31–34.
T. L. Smith, M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, F. C. Tenover, M. J. Zervos, J. D. Band, E. White and W. R. Jarvis, Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group, N. Engl. J. Med., 1999, 340, 493–501.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gad, F., Zahra, T., Francis, K.P. et al. Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci 3, 451–458 (2004). https://doi.org/10.1039/b311901g
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/b311901g